Orphacol and Ribociclib Succinate

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Ribociclib may reduce the effectiveness of cholic acid in treating your condition. Talk to you doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

GENERALLY AVOID: Coadministration with inhibitors of the bile salt efflux pump (BSEP) may exacerbate accumulation of conjugated bile salts in the liver and lead to clinical symptoms in patients treated with cholic acid.

MANAGEMENT: Concomitant use of cholic acid with drugs that inhibit canalicular membrane bile acid transporters such as the BSEP should generally be avoided. If coadministration is required, close monitoring of serum transaminases and bilirubin is recommended. In addition, serum and urine bile acid levels should be monitored, and the cholic acid dose adjusted accordingly.

Orphacol

Generic Name: cholic acid

Brand name: Cholbam

Synonyms: Cholic acid, Cholic Acid

What is Orphacol?

Ribociclib Succinate

Generic Name: ribociclib

Brand name: Kisqali

Synonyms: Ribociclib

What is Ribociclib Succinate?